Columbia Wanger Asset Management’s ResMed RMD Stock Holding History

Columbia Wanger Asset Management’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$28.7M	Hold	338,935	–	–	0.43%	105
2017 Q3	$26.1M	Sell	338,935 -134,873	-28%	-$10.3M	0.39%	110
2017 Q2	$36.9M	Sell	473,808 -166,505	-26%	-$11.9M	0.53%	85
2017 Q1	$46.1M	Sell	640,313 -45,788	-7%	-$3.16M	0.65%	58
2016 Q4	$42.6M	Sell	686,101 -337,245	-33%	-$20.7M	0.6%	65
2016 Q3	$66.3M	Sell	1,023,346 -22,653	-2%	-$1.51M	0.87%	27
2016 Q2	$66.1M	Buy	+1,045,999	New	+$61.7M	0.77%	36

Other funds holding RMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Columbia Wanger Asset Management's RMD Position: Q4 2017 in Review

Columbia Wanger Asset Management held its ResMed (RMD) position steady in Q4 2017 at 338,935 shares worth $28.7M. The position accounts for 0.43% of the portfolio, ranked #105.

Columbia Wanger Asset Management first reported a position in RMD in Q2 2016 and has held it in 7 quarters since. The position peaked at $66.3M in Q3 2016. 415 funds tracked by Wall St. Rank hold RMD as of Q4 2017.

Columbia Wanger Asset Management held 338,935 shares of ResMed worth $28.7M as of Q4 2017.
Columbia Wanger Asset Management left its ResMed share count unchanged in Q4 2017.
ResMed made up 0.43% of Columbia Wanger Asset Management's portfolio in Q4 2017, its #105 holding.
Columbia Wanger Asset Management first reported a position in ResMed in Q2 2016 and has held it in 7 quarters since.
Columbia Wanger Asset Management's ResMed position peaked at $66.3M in Q3 2016.
415 funds tracked by Wall St. Rank held ResMed as of Q4 2017.

Based on Columbia Wanger Asset Management's 13F filing for Q4 2017, filed 13 Feb 2018.